Risk Adapted Therapy in Diffuse Large B Cell Lymphoma
Status:
Unknown status
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
This randomized phase II trial is studying two different combination chemotherapy regimens to
compare how well they work in treating patients with diffuse large B-cell lymphoma.